Seres Therapeutics
MCRB
#8838
Rank
โ‚น9.53 B
Marketcap
โ‚น54.71
Share price
-6.92%
Change (1 day)
-13.58%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -โ‚น11.03 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚น8.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น11.25 Billion34.63%
2023 -โ‚น8.36 Billion-59.97%
2022 -โ‚น20.87 Billion289.57%
2021 -โ‚น5.36 Billion-27.3%
2020 -โ‚น7.37 Billion23%
2019 -โ‚น6 Billion-30.11%
2018 -โ‚น8.58 Billion9.73%
2017 -โ‚น7.82 Billion-0.74%
2016 -โ‚น7.88 Billion70.96%
2015 -โ‚น4.61 Billion257.11%
2014 -โ‚น1.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น20.77 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น21.84 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น36.44 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA